Search results
Results from the WOW.Com Content Network
In 2020, Bayer settled most of the then-pending Roundup cases for up to $9.6 billion but failed to get a settlement covering future cases. More than 50,000 claims remain pending.
Earlier, Bayer said the number of U.S. plaintiffs blaming Roundup and other glyphosate-based weedkillers for their cancer continued to rise by 5,000 to 18,400, as a litigation wave that has ...
Bayer, which acquired Roundup with its purchase of Monsanto for $63 billion in 2018, agreed in June to pay around $11 billion to settle the lawsuits, which have pummeled the company's share price.
More than 42,700 plaintiffs claim Roundup causes a type of cancer called non-Hodgkin's lymphoma. Bayer to date has lost three U.S. jury trials in the Roundup litigation. The company is appealing ...
Bayer CEO Werner Baumann said the decision to settle the lawsuits was the right one in order to end a long period of uncertainty. Bayer reaches $10.5 billion settlement in Roundup cancer lawsuits ...
In June 2020, Bayer agreed to settle over a hundred thousand Roundup lawsuits, agreeing to pay $8.8 to $9.6 billion to settle those claims, and $1.5 billion for any future claims. The settlement does not include three cases that have already gone to jury trials and are being appealed. [63] However the settlement was not allowed to cover future ...
Bayer said it has set aside about $16 billion to deal with Roundup lawsuits, including more than $10 billion it has already paid out in settlements. It has lost other cases at trial.
Bayer AG, after more than a year of talks, agreed to pay as much as $10.9 billion to settle close to 100,000 U.S. lawsuits claiming that its widely-used weedkiller Roundup caused cancer, resolving ...